Glyclopyramide

Source: Wikipedia, the free encyclopedia.
Glyclopyramide
Clinical data
Routes of
administration		Oral
ATC code
  • none
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
  • 4-chloro-N-[(pyrrolidin-1-ylamino)carbonyl]benzenesulfonamide
JSmol)
  • C1CCN(C1)NC(=O)NS(=O)(=O)C2=CC=C(C=C2)Cl
  • InChI=1S/C11H14ClN3O3S/c12-9-3-5-10(6-4-9)19(17,18)14-11(16)13-15-7-1-2-8-15/h3-6H,1-2,7-8H2,(H2,13,14,16) ☒N
  • Key:HNSCCNJWTJUGNQ-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Glyclopyramide (

INN, marketed under the tradename Deamelin-S) is a sulfonylurea drug used in the treatment of diabetes. It has been marketed in Japan
since 1965.

It is classified as second generation.[1]

References

  1. PMID 14570054
    .

External links